AMERICAN SHARED HOSPITAL SERVICES Line of Credit Facility, Maximum Amount Outstanding During Period
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Line of Credit Facility, Maximum Amount Outstanding During Period of $9.00 million for the 12-month period ending 2014-12-31, per its 10-K filed 2017-03-27.
Discontinued › Notes › Debt
us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod · last filed 2017-03-27
- AMERICAN SHARED HOSPITAL SERVICES line of credit facility, maximum amount outstanding during period for the quarter ending 2014-12-31 was $0.00.
- AMERICAN SHARED HOSPITAL SERVICES line of credit facility, maximum amount outstanding during period for the quarter ending 2014-09-30 was $0.00.
- AMERICAN SHARED HOSPITAL SERVICES line of credit facility, maximum amount outstanding during period for the quarter ending 2014-06-30 was $0.00.
- AMERICAN SHARED HOSPITAL SERVICES line of credit facility, maximum amount outstanding during period for the quarter ending 2014-03-31 was $9.00M, a 0.00% change year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES line of credit facility, maximum amount outstanding during period for fiscal 2014 was $9.00M, a 0.00% change from fiscal 2013.
- AMERICAN SHARED HOSPITAL SERVICES line of credit facility, maximum amount outstanding during period for fiscal 2013 was $9.00M, a 0.00% change from fiscal 2012.
- AMERICAN SHARED HOSPITAL SERVICES line of credit facility, maximum amount outstanding during period for fiscal 2012 was $9.00M.
| Period end | Line of Credit Facility, Maximum Amount Outstanding During Period 3 month | Line of Credit Facility, Maximum Amount Outstanding During Period 6 month | Line of Credit Facility, Maximum Amount Outstanding During Period 9 month | Line of Credit Facility, Maximum Amount Outstanding During Period 12 month |
|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | $0.00 derived: sum of 2 quarters · filed 2017-03-27 | $0.00 derived: sum of 3 quarters · filed 2017-03-27 | $9.00M 10-K · filed 2017-03-27 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $0.00 derived: sum of 2 quarters · filed 2014-11-14 | $9.00M 10-Q · filed 2014-11-14 | $9.00M derived: sum of 4 quarters · filed 2015-04-01 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-15 | $9.00M 10-Q · filed 2014-08-15 | $9.00M derived: sum of 3 quarters · filed 2015-04-01 | $9.00M derived: sum of 4 quarters · filed 2015-04-01 |
| 2014-03-31 | $9.00M 10-Q · filed 2014-05-15 | $9.00M derived: sum of 2 quarters · filed 2015-04-01 | $9.00M derived: sum of 3 quarters · filed 2015-04-01 | $9.00M derived: sum of 4 quarters · filed 2015-04-01 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-01 | $0.00 derived: sum of 2 quarters · filed 2015-04-01 | $0.00 derived: sum of 3 quarters · filed 2015-04-01 | $9.00M 10-K · filed 2015-04-01 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $9.00M 10-Q · filed 2013-11-14 | $9.00M derived: sum of 4 quarters · filed 2013-11-14 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $9.00M 10-Q · filed 2013-08-14 | $9.00M derived: sum of 3 quarters · filed 2013-08-14 | $9.00M derived: sum of 4 quarters · filed 2013-08-14 |
| 2013-03-31 | $9.00M 10-Q · filed 2013-05-15 | $9.00M derived: sum of 2 quarters · filed 2013-05-15 | $9.00M derived: sum of 3 quarters · filed 2013-05-15 | |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | $0.00 derived: sum of 2 quarters · filed 2013-03-29 | $9.00M 10-K · filed 2013-03-29 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | $9.00M 10-Q · filed 2012-11-14 | ||
| 2012-06-30 | $9.00M 10-Q/A · filed 2012-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |